Laboratory rats react well to an experimental anti-stroke vaccine
Researchers at the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health, recently concluded a test study showing that they may be on the right track developing an anti-stroke vaccine. Doctors performed a study of a vaccine they call E-selectin, the active ingredient being a protein that normally causes inflammation in cells lining the walls of blood vessels, but seems, actually, to spur the body into protecting itself from some of the main causes of stroke.